(Q45159520)

10 December 2017

title

Overproduction of BCR-ABL induces apoptosis in imatinib mesylate-resistant cell lines (English)

1 reference

10 December 2017

1 reference

Vanessa Desplat

1

1 reference

10 December 2017

Francis Belloc

2

1 reference

10 December 2017

Valérie Lagarde

3

1 reference

10 December 2017

Catherine Boyer

4

1 reference

10 December 2017

Junia V Melo

5

1 reference

10 December 2017

Josy Reiffers

6

1 reference

10 December 2017

Vincent Praloran

7

1 reference

10 December 2017

François-Xavier Mahon

8

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

10 December 2017

1 reference

10 December 2017

volume

103

1 reference

10 December 2017

issue

1

1 reference

10 December 2017

page(s)

102-110

1 reference

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR–ABL tyrosine kinase, CGP 57148

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Restoration of sensitivity to STI571 in STI571-resistant chronic myeloid leukemia cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Rapid detection of phosphotyrosine proteins by flow cytometric analysis in Bcr-Abl-positive cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Functional cooperation among Ras, STAT5, and phosphatidylinositol 3-kinase is required for full oncogenic activities of BCR/ABL in K562 cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20758

7 January 2021

Identifiers

DOI

10.1002/CNCR.20758

1 reference

10 December 2017

1 reference